An increase in cell number at completion of therapy may develop as an indicator of early relapse

@article{Pachmann2007AnII,
  title={An increase in cell number at completion of therapy may develop as an indicator of early relapse},
  author={K. Pachmann and R. Dengler and K. Lobodasch and Frank Fr{\"o}hlich and T. Kroll and M. Rengsberger and R. Schubert and U. Pachmann},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2007},
  volume={134},
  pages={59-65}
}
PurposeTreatment efficiency of adjuvant therapy in breast cancer is only revealed after several years by statistical evaluation and gives no answer for the individual patient. We here present a method to analyze the response to adjuvant chemotherapy online in individual patients.Methods/resultsIn 25 consecutive non-metastatic primary breast cancer patients adjuvant fluorouracil/epirubicin/cyclophosphamid (FEC) or EC followed by taxane (EC-T) or cyclophosphamid/methotrexate/fluorouracil (CMF… Expand
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.
Review: Biological relevance of disseminated tumor cells in cancer patients
Clinical significance of circulating tumor cells in breast cancer patients
...
1
2
3
4
...

References

SHOWING 1-10 OF 31 REFERENCES
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Ineffectiveness of Doxorubicin Treatment on Solitary Dormant Mammary Carcinoma Cells or Late-developing Metastases
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.
[Detection of disseminated tumor cells in bone marrow--currently of no practical therapeutic value].
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
...
1
2
3
4
...